Skip to main content
. 2019 Sep 22;14(4):299–304. doi: 10.30699/ijp.2019.96713.1952

Table 4.

Comparison of fibroblastic growth factor receptor-1 (FGFR1) gene amplification according to tumor grade and stage of 84 patients with TNBCs

FGFR1 gene amplification
P-value
Positive Negative
Tumor grade 1 2 (2.3%) 5 (6%) 0.549
2 14 (16.9%) 20 (24.1%)
3 12 (14.5%) 30 (36.1%)
Stage 1 0 2 (3.3%) 0.116
2 17 (19.54%) 19 (22.6%)
3 9 (10.71%) 26 (30.95%)
4 29 (34.52%) 9 (10.71%)